Glucosamine and Chondroitin May Lower Risk of Colon Cancer
Glucosamine and chondroitin are most commonly taken for joint health, but a recent study suggests that taking a glucosamine and chondroitin supplement may also reduce the risk of colorectal cancer by 23%.
Participants in the study included 68,466 women and 27,934 men who took part in the Nurses’ Health Study and Health Professionals Follow-Up Study. During the study period, there were 672 cases of colorectal cancer.
After examining the data, the researchers found that taking glucosamine was associated with a 21% reduction in risk and that chondroitin was associated with a 23% reduction. Taking both of them together was associated with a 23% reduction in risk. These results held even after researchers accounted for factors including sex, BMI, and physical activity.
Researchers from the Memorial Sloan Kettering Cancer Center in New York conducted the study. It was published on November 1, 2016, in the International Journal of Cancer.
Glucosamine is produced naturally in the body and helps with joint function. Glucosamine supplements have been found to help with osteoarthritis, reducing joint pain and improving joint function.
Chondroitin is found in and around the cells of cartilage, and provides cartilage with strength and resilience. Previous research has found that chondroitin may help ease the pain of arthritis and osteoporosis, lower cholesterol and possibly help with ulcerative colitis and Crohn’s disease.